Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Shuxin Anshen decoction
- Development stage
- Unknown
- Lead developer
- Guangdong Provincial Hospital of Traditional Chinese Medicine
- Modality
- Small Molecules
- Administration
- Oral
01
Overview
Shuxin Anshen decoction (SXAS) is a Traditional Chinese Medicine (TCM) herbal formula developed by the Guangdong Provincial Hospital of Chinese Medicine for the treatment of chronic insomnia, specifically targeting patients with Yang deficiency syndrome (often characterized as Heart-Kidney Yang deficiency). The formula is composed of several botanical ingredients, including *Ziziphus jujuba* var. *spinosa*, *Cistanche deserticola*, and *Morinda officinalis*, which are traditionally used to warm the Yang, tonify the kidneys, and calm the spirit (Anshen). Mechanistically, research indicates that SXAS may alleviate sleep disturbances by modulating the hypothalamic-pituitary-adrenal (HPA) axis, regulating the balance of excitatory and inhibitory neurotransmitters such as gamma-aminobutyric acid (GABA) and serotonin (5-HT), and potentially influencing the gut-microbiota-brain axis. It is primarily utilized as a hospital preparation within the Guangdong Provincial Hospital system and has been the subject of clinical trials to validate its efficacy and safety in chronic insomnia populations.
- Other names
- Shuxin Anshen formulaSXAS decoction舒心安神方舒心安神汤
02
Targets
GABA-B (Gamma-aminobutyric acid receptor type B)5-HT (Serotonin receptors)
Beyond the preview
Go deeper on Shuxin Anshen decoction.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Shuxin Anshen decoction.